Chopchini

<h3> Absolute Contraindications of Chopchini </h3> <h4> Pregnancy or breastfeeding (Avoid during pregnancy/lactation)</h4> <ul> <li> 🤰</li> <li> Recommendation: Do not use Chopchini during pregnancy or while breastfeeding; consult your healthcare provider for alternatives.</li> <li> Reasoning: Some Smilax species contain flavonoids and other compounds with estrogenic or anti-estrogenic activity; safety for fetal development and lactation is not established, so use is avoided until proven safe.</li> <li> Scientific_Study_Title: Estrogenic and anti-estrogenic compounds from the Thai medicinal plant, Smilax corbularia (Smilacaceae).</li> <li> Scientific_Study_Authors: Wungsintaweekul B, Umehara K, Miyase T, Noguchi H.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21315392/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: The authors isolated multiple flavonoid and related compounds from Smilax corbularia and tested them in estrogen-responsive human breast cancer cell lines (MCF-7, T47D). The study found that specific flavanonol rhamnosides had suppressive effects on estradiol-induced cell proliferation at low micromolar concentrations, while some acetylated derivatives exhibited estrogenic activity at higher concentrations. Because the plant yields both estrogenic and anti-estrogenic molecules, the paper highlights that Smilax extracts can modulate estrogen signaling in biological systems - a reason for caution in pregnancy and lactation when hormonal balance and fetal exposure matter.</p> </li> </ul> <h4> Known hypersensitivity / asthma or prior occupational allergy to sarsaparilla</h4> <ul> <li> ⚠️</li> <li> Recommendation: Do not use Chopchini if you have a known allergy to Smilax or if you have asthma that is worsened by herbal dusts; avoid inhaling root powder or dust.</li> <li> Reasoning: Case reports document that sarsaparilla root dust can sensitize and trigger occupational asthma and allergic responses in exposed people.</li> <li> Scientific_Study_Title: Occupational asthma caused by sarsaparilla root dust.</li> <li> Scientific_Study_Authors: Vandenplas O, Depelchin S, Toussaint G, Delwiche JP, Weyer RV, Saint-Remy JM.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8648042/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: The paper reports a clinical case of occupational asthma attributed to inhalation of sarsaparilla (Smilax) root dust. Diagnostic testing linked symptoms and serologic/immunologic markers to exposure; the report warns that handling or processing dried root material can provoke IgE-mediated respiratory sensitization in susceptible individuals. The case supports the need to avoid exposure and use protective measures or avoid use entirely in people with known respiratory sensitivity.</p> </li> </ul> <h4> Concurrent methotrexate therapy (patients on methotrexate) </h4> <ul> <li> 💊</li> <li> Recommendation: Avoid taking Chopchini (especially Smilax glabra preparations) with methotrexate unless supervised by a clinician; do not self-combine.</li> <li> Reasoning: Preclinical pharmacokinetic data show Smilax glabra can significantly alter methotrexate blood and tissue levels by modulating drug transporters, which may change efficacy or toxicity of methotrexate.</li> <li> Scientific_Study_Title: Smilax glabra Rhizoma affects the pharmacokinetics and tissue distribution of methotrexate by increasing the P-glycoprotein mRNA expression in rats after oral administration.</li> <li> Scientific_Study_Authors: Li Y, Deng S, Zhao Y, Liu L, Zhao R.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28944899/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: In a rat model, co-administration of Smilax glabra rhizome extract with methotrexate significantly decreased plasma area under the curve (AUC) and Cmax for methotrexate (reductions of ~44.5% and ~48.2% respectively) while altering tissue distribution in an organ-dependent manner. The herb increased intestinal P-glycoprotein mRNA expression, suggesting enhanced efflux and altered absorption/elimination of methotrexate. These pharmacokinetic changes imply clinically relevant interactions that could reduce methotrexate exposure or shift distribution, supporting avoidance or tight monitoring when combined.</p> </li> </ul> <h4> Severe renal impairment / volume depletion (patients with advanced kidney disease)</h4> <ul> <li> 🩺</li> <li> Recommendation: Avoid or use under specialist supervision if you have severe kidney disease or are on potassium-wasting diuretics; monitor fluid and electrolytes closely.</li> <li> Reasoning: Several Smilax species show measurable diuretic effects in animal studies; in patients with compromised renal function this could worsen fluid or electrolyte imbalances.</li> <li> Scientific_Study_Title: Diuretic activity of some Smilax canariensis fractions.</li> <li> Scientific_Study_Authors: Abdala S, Martín-Herrera D, Benjumea D, Gutiérrez SD.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22289346/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: Experimental administration of aqueous and organic fractions from Smilax canariensis in saline-loaded rodents produced dose-dependent increases in urine output and alterations in urinary electrolytes (Na+, K+). Certain intermediate-polarity fractions increased diuresis to levels comparable with reference diuretics (hydrochlorothiazide, furosemide) in the model. The authors conclude that phytochemicals in Smilax can produce clinically meaningful diuretic actions, supporting caution in patients where diuresis or electrolyte loss is harmful.</p> </li> </ul> <h3> Relative Contraindications of Chopchini </h3> <h4> Use with xanthine oxidase inhibitors (e.g., allopurinol) - gout medications</h4> <ul> <li> ↔️</li> <li> Recommendation: Use caution and consult your physician if combining Chopchini with allopurinol; dose adjustment or monitoring may be needed.</li> <li> Reasoning: Certain Smilax saponins and fractions have independent uricosuric and xanthine oxidase inhibitory effects and showed additive or synergistic reduction of serum uric acid when combined with allopurinol in animal studies.</li> <li> Scientific_Study_Title: Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine.</li> <li> Scientific_Study_Authors: Wu XH, Wang CZ, Wang SQ, Mi C, He Y, Zhang J, Zhang YW, Anderson S, Yuan CS.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25617746/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: In a hyperuricemic mouse model, combined administration of Smilax riparia saponins with allopurinol produced greater declines in serum uric acid and increases in urinary uric acid than allopurinol alone. Mechanistic assays demonstrated inhibition of xanthine oxidase and modulation of renal urate transporters (down-regulation of URAT1 and up-regulation of OAT1), suggesting a synergistic hypouricemic effect. While promising for gout control, the result indicates potential for unexpected additive pharmacologic impact when combined with allopurinol.</p> </li> </ul> <h4> Hormone-sensitive conditions (breast, uterine, ovarian cancers)</h4> <ul> <li> ⚕️</li> <li> Recommendation: Avoid or consult an oncologist/endocrinologist before using Chopchini if you have hormone-sensitive cancer or are on hormonal therapy.</li> <li> Reasoning: Some Smilax extracts contain compounds that can act as estrogen agonists or antagonists in cellular assays; such activity could theoretically influence hormone-dependent disease processes or therapy.</li> <li> Scientific_Study_Title: Estrogenic and anti-estrogenic compounds from the Thai medicinal plant, Smilax corbularia (Smilacaceae).</li> <li> Scientific_Study_Authors: Wungsintaweekul B, Umehara K, Miyase T, Noguchi H.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21315392/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: The authors isolated multiple flavonoid derivatives from Smilax corbularia and tested their influence on estrogen-responsive human breast cancer cell lines. Results showed both estrogenic and anti-estrogenic activities depending on compound and concentration, indicating Smilax extracts can modulate estrogen receptor pathways. Given this dual potential, caution is advised for people with hormone-sensitive conditions due to possible interference with disease biology or endocrine therapies.</p> </li> </ul> <h4> Use with potent P-glycoprotein substrates or narrow-therapeutic-index drugs</h4> <ul> <li> 🔁</li> <li> Recommendation: Consult your prescriber before combining Chopchini with drugs that rely on P-glycoprotein transport (e.g., certain chemotherapeutics, immunosuppressants); monitoring or spacing doses may be required.</li> <li> Reasoning: Smilax glabra increased intestinal P-glycoprotein expression in animal models, altering absorption and tissue distribution of co-administered drugs like methotrexate; similar effects could affect other P-gp substrates.</li> <li> Scientific_Study_Title: Smilax glabra Rhizoma affects the pharmacokinetics and tissue distribution of methotrexate by increasing the P-glycoprotein mRNA expression in rats after oral administration.</li> <li> Scientific_Study_Authors: Li Y, Deng S, Zhao Y, Liu L, Zhao R.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28944899/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: The study demonstrated that co-administration of Smilax glabra with methotrexate in rats reduced methotrexate systemic exposure and Cmax while increasing intestinal P-glycoprotein mRNA expression ~2.5-fold. These changes suggest Smilax preparations can modify drug transporters and thus the pharmacokinetics of drugs that are P-gp substrates, warranting caution with narrow-therapeutic-index medications.</p> </li> </ul>